AIHealthcare Analytics

Knowledge Wiki

Wiki › MHRA Homes In on Personalised Healthcare and Tech in New 2030 Strategy

MHRA Homes In on Personalised Healthcare and Tech in New 2030 Strategy

OVERVIEW
Rev 5 Oct 19, 2026 10:20 UTC 1 sources

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has released a 2030 strategy emphasizing personalized healthcare and technology integration, including explicit focus on AI-enabled medical devices and data-driven therapeutics. The strategy positions AI and digital health as core to the agency's regulatory evolution. The MHRA's 2030 strategy commits to developing regulatory frameworks that enable AI innovation while maintaining patient safety standards. Key priorities include: streamlined approval pathways for AI-enabled devices, real-world evidence generation requirements, post-market surveillance of adaptive AI systems, and guidance for software-as-a-medical-device (SaMD) classification and oversight. The UK's regulatory approach differs from the FDA's, emphasizing adaptive oversight frameworks that can accommodate AI systems that change over time. However, implementation challenges remain: how to validate AI systems that continuously learn and adapt, how to ensure real-world performance matches clinical trial results, and how to maintain regulatory oversight as AI capabilities advance faster than regulatory guidance can evolve. ---

Sources: harvested
🔒

Subscribe to read full wiki analysis

Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.

View Plans & Subscribe

New users get a 7-day trial — no credit card required.

← Back to Wiki Index